Logo image of REBN

REBORN COFFEE INC (REBN) Stock Fundamental Analysis

NASDAQ:REBN - Nasdaq - US75618M3051 - Common Stock - Currency: USD

2.68  -0.03 (-1.11%)

After market: 2.7296 +0.05 (+1.85%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to REBN. REBN was compared to 40 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of REBN have multiple concerns. REBN is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

REBN had negative earnings in the past year.
REBN had a negative operating cash flow in the past year.
REBN Yearly Net Income VS EBIT VS OCF VS FCFREBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -1M -2M -3M

1.2 Ratios

REBN has a Return On Assets of -38.44%. This is amonst the worse of the industry: REBN underperforms 92.50% of its industry peers.
With a Return On Equity value of -159.16%, REBN is not doing good in the industry: 92.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -38.44%
ROE -159.16%
ROIC N/A
ROA(3y)-52.89%
ROA(5y)N/A
ROE(3y)-208.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
REBN Yearly ROA, ROE, ROICREBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 100 -100 -200

1.3 Margins

REBN has a Gross Margin of 71.79%. This is amongst the best in the industry. REBN outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of REBN has grown nicely.
The Profit Margin and Operating Margin are not available for REBN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.02%
GM growth 5YN/A
REBN Yearly Profit, Operating, Gross MarginsREBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

REBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REBN has more shares outstanding
Compared to 1 year ago, REBN has a worse debt to assets ratio.
REBN Yearly Shares OutstandingREBN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 500K 1M 1.5M
REBN Yearly Total Debt VS Total AssetsREBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M 8M

2.2 Solvency

REBN has an Altman-Z score of -2.48. This is a bad value and indicates that REBN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.48, REBN is not doing good in the industry: 92.50% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.65 indicates that REBN is somewhat dependend on debt financing.
REBN's Debt to Equity ratio of 0.65 is in line compared to the rest of the industry. REBN outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z -2.48
ROIC/WACCN/A
WACC8.81%
REBN Yearly LT Debt VS Equity VS FCFREBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 0.45 indicates that REBN may have some problems paying its short term obligations.
REBN has a Current ratio of 0.45. This is amonst the worse of the industry: REBN underperforms 95.00% of its industry peers.
A Quick Ratio of 0.37 indicates that REBN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.37, REBN is doing worse than 67.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.37
REBN Yearly Current Assets VS Current LiabilitesREBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.04% over the past year.
The Revenue has grown by 42.94% in the past year. This is a very strong growth!
REBN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 95.81% yearly.
EPS 1Y (TTM)22.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.54%
Revenue 1Y (TTM)42.94%
Revenue growth 3Y95.81%
Revenue growth 5YN/A
Sales Q2Q%-9.61%

3.2 Future

REBN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.46% yearly.
The Revenue is expected to grow by 68.65% on average over the next years. This is a very strong growth
EPS Next Y61.54%
EPS Next 2Y61.72%
EPS Next 3Y57.72%
EPS Next 5Y54.46%
Revenue Next Year129.85%
Revenue Next 2Y94.48%
Revenue Next 3Y78.51%
Revenue Next 5Y68.65%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
REBN Yearly Revenue VS EstimatesREBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
REBN Yearly EPS VS EstimatesREBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for REBN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 32.84 indicates a quite expensive valuation of REBN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of REBN is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.38, REBN is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 32.84
REBN Price Earnings VS Forward Price EarningsREBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
REBN Per share dataREBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
REBN's earnings are expected to grow with 57.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.72%
EPS Next 3Y57.72%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for REBN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REBORN COFFEE INC

NASDAQ:REBN (4/25/2025, 6:17:49 PM)

After market: 2.7296 +0.05 (+1.85%)

2.68

-0.03 (-1.11%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)11-14 2022-11-14/amc
Earnings (Next)N/A N/A
Inst Owners2.67%
Inst Owner Change0%
Ins Owners48.02%
Ins Owner Change-0.73%
Market Cap12.25M
Analysts82.86
Price TargetN/A
Short Float %6.99%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 32.84
P/S 1.97
P/FCF N/A
P/OCF N/A
P/B 4.82
P/tB 4.82
EV/EBITDA N/A
EPS(TTM)-2.13
EYN/A
EPS(NY)0.08
Fwd EY3.04%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS1.36
BVpS0.56
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.44%
ROE -159.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.79%
FCFM N/A
ROA(3y)-52.89%
ROA(5y)N/A
ROE(3y)-208.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.02%
GM growth 5YN/A
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 921.25%
Cap/Sales 44.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.37
Altman-Z -2.48
F-Score4
WACC8.81%
ROIC/WACCN/A
Cap/Depr(3y)304%
Cap/Depr(5y)N/A
Cap/Sales(3y)17.81%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.54%
EPS Next Y61.54%
EPS Next 2Y61.72%
EPS Next 3Y57.72%
EPS Next 5Y54.46%
Revenue 1Y (TTM)42.94%
Revenue growth 3Y95.81%
Revenue growth 5YN/A
Sales Q2Q%-9.61%
Revenue Next Year129.85%
Revenue Next 2Y94.48%
Revenue Next 3Y78.51%
Revenue Next 5Y68.65%
EBIT growth 1Y6.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.48%
EBIT Next 3Y87.85%
EBIT Next 5Y77.52%
FCF growth 1Y4.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.35%
OCF growth 3YN/A
OCF growth 5YN/A